Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Rick Doblin · Said 4 Apr 2016 · doblin-0038

Quote

Not a forecast

“After such approval, there would be an initial three-year period of data exclusivity where MAPS might be the only source of FDA-regulated marijuana for PTSD. After that, marijuana would become a generic medicine.”
· From the Desk of Rick Doblin, Ph.D. – Spring 2016 (MAPS Bulletin Vol. 26, No. 1) · own post

Conditional on MAPS one day obtaining FDA approval to market the marijuana plant for PTSD symptoms: a three-year data exclusivity period, then generic status.

Descriptive, retrospective, or a statement of preference; no future state asserted.

← Earlier · Later → · All statements